Article
The relationship between EGFR gene mutation status and ERCC1 in lung adenocarcinoma of Chinese patients receiving platinum-based neoadjuvant chemotherapy.
Oncology research - 1 Jan 2012
Ke Hong-Gang, Zhou Xiao-Yu, Shen Yi, You Qing-Sheng, Yan Yu, Shen Zhen-Ya
Abstract excerpt
The specific aim of this study was to assess the relationship between the mutation status of the epidermal growth factor receptor (EGFR) gene and excision repair cross-complementation group 1 (ERCC1) in lung adenocarcinoma of patients that received platinum-based neoadjuvant chemotherapy. One hundred and seven primary lung adenocarcinoma patients with 22 stage IIa, 61 stage IIb, and 24 stage IIIa (TNM staging...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
